Turning Point Therapeutics, Inc.
COMBINATION THERAPY INVOLVING DIARYL MACROCYCLIC COMPOUNDS
Last updated:
Abstract:
The present disclosure relates to methods and compositions for treating cancer with a diaryl macrocycle in combination with at least one other cancer therapeutic, such as an EGFR inhibitor.
Status:
Application
Type:
Utility
Filling date:
25 Jan 2018
Issue date:
19 Dec 2019